Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence

被引:0
|
作者
Ian C Talbot [1 ]
机构
[1] Academic Department of Pathology St. Mark’s Hospital Cancer Research UK Colorectal Cancer Unit Harrow HA1 3UJ London United Kingdom
关键词
Colorectal neoplasm; p16; CDK4; Immuno-; cytochemistry;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100214 ;
摘要
AIM: To study the correlation between the patterns of subcellular expression of p16 and CDK4 in colorectal epithelia in the normal-adenoma-carcinoma sequence. METHODS: Paraffin sections of 43 cases of normal colorectal epithelia and corresponding adenomas as well as carcinomas were analysed immunocytochemically for subcellular expression of p16 and CDK4 proteins. RESULTS: Most carcinomas showed more cytoplasmic overexpression for p16 and CDK4 than the adenomas from which they arised or the adjacent normal mucosa. Most normal or non-neoplastic epithelia showed more p16 and CDK4 expression in the nucleus than their adjacent adenomas and carcinomas. There was a significant difference between the subcellular expression pattern of p16 and CDK4 in normal-adenoma-carcinoma sequence epithelia (P < 0.001). Neither p16 nor CDK4 subcellular patterns correlated with histological grade or Dukes’ stage. CONCLUSION: Interaction of expression of p16 and CDK4 plays an important role in the Rb/p16 pathway. Overexpression of p16 and CDK4 in the cytoplasm, as well as loss expression of p16 in the nucleus might be important in the evolution of colorectal carcinoma from adenoma and, of adenoma from normal epithelia.
引用
收藏
页码:6391 / 6396
页数:6
相关论文
共 50 条
  • [21] p16 and cdk4 are inversely expressed in malignant melanoma of higher Clark Levels
    OlaizolaHorn, S
    Ermitsch, M
    Sterry, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 122 - 122
  • [22] Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma
    Asp, J
    Inerot, S
    Block, JA
    Lindahl, A
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, 19 (01) : 149 - 154
  • [23] Analysis of P16, CDK4 and PTEN immunoexpression in oral melanocytic nevi and melanomas
    Santana, T.
    Queiroz, A.
    Trierveiler, M.
    VIRCHOWS ARCHIV, 2020, 477 : S321 - S322
  • [24] Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy
    Poomsawat, Sopee
    Buajeeb, Waranun
    Khovidhunkit, Siribang-on Piboonniyom
    Punyasingh, Jirapa
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (04) : 294 - 299
  • [25] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma.
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    LABORATORY INVESTIGATION, 1998, 78 (01) : 13A - 13A
  • [26] Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma
    Zuo, L
    Weger, J
    Yang, QB
    Goldstein, AM
    Tucker, MA
    Walker, GJ
    Hayward, N
    Dracopoli, NC
    NATURE GENETICS, 1996, 12 (01) : 97 - 99
  • [27] Immunohistochemical detection of CDK4 and p16(INK4) proteins in cutaneous malignant melanoma
    Wang, YL
    Uhara, H
    Yamazaki, Y
    Nikaido, T
    Saida, T
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (02) : 269 - 275
  • [28] P16(INK4) - AN SPECIFIC INHIBITOR OF THE CDK4/CYCLIN-D KINASE
    BEACH, D
    SERRANO, M
    HANNON, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 207 - 207
  • [29] P16(INK4) - AN SPECIFIC INHIBITOR OF THE CDK4/CYCLIN-D KINASE
    BEACH, D
    SERRANO, M
    HANNON, GJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 161 - 161
  • [30] Several noncontiguous domains of CDK4 are involved in binding to the p16 tumor suppressor protein
    Ceha, HM
    Nasser, I
    Medema, RH
    Slebos, RJC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 550 - 555